Eye Tracking in Patients with Parkinson’s Disease Treated with Nabilone–Results of a Phase II, Placebo-Controlled, Double-Blind, Parallel-Group Pilot Study

The topic of the therapeutic use of cannabinoids in Parkinson’s disease (PD) is broadly discussed and frequently comes up in the outpatient clinic. So far, there are only a few randomized clinical trials assessing the effects of cannabinoids in PD. We are able to demonstrate a reduction in non-motor...

Descripción completa

Detalles Bibliográficos
Autores principales: Ellmerer, Philipp, Peball, Marina, Carbone, Federico, Ritter, Marcel, Heim, Beatrice, Marini, Kathrin, Valent, Dora, Krismer, Florian, Poewe, Werner, Djamshidian, Atbin, Seppi, Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139535/
https://www.ncbi.nlm.nih.gov/pubmed/35625047
http://dx.doi.org/10.3390/brainsci12050661

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139535/
https://www.ncbi.nlm.nih.gov/pubmed/35625047
http://dx.doi.org/10.3390/brainsci12050661

Ejemplares similares